Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitus;Impacto del tratamiento adyuvante con cilostazol comparado con dosis altas de mantenimiento de clopidogrel en pacientes con diabetes mellitus y respuesta subóptima

Revista Espanola de Cardiologia

Volumn 65, Issue 1, 2012, Pages 105-106

  Ferreiro, José L ^a,b   Ueno, Masafumi ^a   Desai, Bhaloo ^a   Capranzano, Piera ^a   Capodanno, Davide ^a   Angiolillo, Dominick J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL; CLOPIDOGREL;

ADJUVANT THERAPY; COMPARATIVE EFFECTIVENESS; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LETTER; MAINTENANCE DRUG DOSE; TREATMENT RESPONSE;

ASPIRIN; BLOOD COAGULATION; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, PURINERGIC P2Y12; TETRAZOLES; THROMBOSIS; TICLOPIDINE;

EID: 84655161920     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.04.008     Document Type: Letter

References (6)

1. 12 de adenosina difosfato plaquetario: efectos beneficiosos y limitaciones de las estrategias terapéuticas actuales y perspectivas futuras Rev Esp Cardiol 63 2010 60 76
2. J.L. Ferreiro, and D.J. Angiolillo Diabetes and antiplatelet therapy in acute coronary syndrome Circulation 123 2011 798 813
3. D.J. Angiolillo, S.B. Shoemaker, B. Desai, H. Yuan, R.K. Charlton, and E. Bernardo Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study Circulation 115 2007 708 716 (Pubitemid 46294761)
4. D.J. Angiolillo, P. Capranzano, S. Goto, M. Aslam, B. Desai, and R.K. Charlton A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study Eur Heart J 29 2008 2202 2211
5. Y.H. Jeong, S.W. Lee, B.R. Choi, I.S. Kim, M.K. Seo, and C.H. Kwak Randomized comparison of adjunctive cilostazol versus high maintenance dose clopidogrel in patients with high post-treatment platelet reactivity: results of the ACCEL-RESISTANCE (Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With Clopidogrel Resistance) randomized study J Am Coll Cardiol 53 2009 1101 1109
6. D.J. Angiolillo, J.J. Badimon, J.F. Saucedo, A.L. Frelinger, A.D. Michelson, and J.A. Jakubowski A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial Eur Heart J 32 2011 838 846